Cargando…

A meta-analysis of obstetric and neonatal outcomes in patients after treatment of hysteroscopic adhesiolysis

INTRODUCTION: Hysteroscopic adhesiolysis is widely performed in women with intrauterine adhesions. Small observational studies have reported the obstetric and neonatal outcomes, but studies with larger sample sizes are few. The aim of this study is to evaluate the obstetric and neonatal outcomes in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wenzhi, Xu, Xin, Xu, Ping, Zhou, Hanglin, Wu, Xiaona, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080075/
https://www.ncbi.nlm.nih.gov/pubmed/37033233
http://dx.doi.org/10.3389/fendo.2023.1126740
_version_ 1785020846432059392
author Wenzhi, Xu
Xin, Xu
Ping, Zhou
Hanglin, Wu
Xiaona, Lin
author_facet Wenzhi, Xu
Xin, Xu
Ping, Zhou
Hanglin, Wu
Xiaona, Lin
author_sort Wenzhi, Xu
collection PubMed
description INTRODUCTION: Hysteroscopic adhesiolysis is widely performed in women with intrauterine adhesions. Small observational studies have reported the obstetric and neonatal outcomes, but studies with larger sample sizes are few. The aim of this study is to evaluate the obstetric and neonatal outcomes in women after hysteroscopic adhesiolysis. METHODS: We conducted a literature search in July 2022 using the PubMed, Embase, the Cochrane Library, and Web of Science databases, and finally, 32 studies (N = 3812) were included. We did a meta-analysis to estimate the prevalence of placenta-related disorders, including placenta previa, placental abruption, placenta accreta, placenta increta, and retained placenta. We also included other obstetric and neonatal outcomes like postpartum hemorrhage, ectopic pregnancy, oligohydramnios, gestational hypertension, gestational diabetes mellitus, and intrauterine growth restriction. The results were presented as odds ratios (ORs) with 95% confidence intervals (CIs) in studies with a control group, but otherwise as prevalence (%) with 95% confidence intervals (CIs). RESULTS: The overall pregnancy and live birth rates were 58.97% and 45.56%, respectively. The prevalence of placenta previa differed in pregnant women who underwent hysteroscopic adhesiolysis compared with those who did not (OR, 3.27; 95% CI, 1.28-8.36). In studies without a comparative group, the pooled rate of placenta accreta was 7% (95% CI, 4-11) in 20 studies; placenta increta was 1% (95% CI, 0-4) in 5 studies; a retained placenta was 11% (95% CI, 5-24) in 5 studies; postpartum hemorrhage was 12% (95% CI, 8-18) in 12 studies; ectopic pregnancy was 1% (95% CI, 0-2) in 13 studies; oligohydramnios was 3% (95% CI, 1-6) in 3 studies; intrauterine growth restriction was 3% (95% CI, 1-8) in 3 studies; gestational hypertension was 5% (95% CI, 2-11) in 4 studies; and diabetes mellitus was 4% (95% CI, 2-7) in 3 studies. DISCUSSION: Due to the paucity of good quality comparative data, the question of whether there is an increased prevalence of obstetric and neonatal complications in women after hysteroscopic adhesiolysis compared with the general population remains unanswered. The findings from this review will provide a basis for more well-designed studies in the future. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=364021, identifier [CRD42022364021].
format Online
Article
Text
id pubmed-10080075
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100800752023-04-08 A meta-analysis of obstetric and neonatal outcomes in patients after treatment of hysteroscopic adhesiolysis Wenzhi, Xu Xin, Xu Ping, Zhou Hanglin, Wu Xiaona, Lin Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: Hysteroscopic adhesiolysis is widely performed in women with intrauterine adhesions. Small observational studies have reported the obstetric and neonatal outcomes, but studies with larger sample sizes are few. The aim of this study is to evaluate the obstetric and neonatal outcomes in women after hysteroscopic adhesiolysis. METHODS: We conducted a literature search in July 2022 using the PubMed, Embase, the Cochrane Library, and Web of Science databases, and finally, 32 studies (N = 3812) were included. We did a meta-analysis to estimate the prevalence of placenta-related disorders, including placenta previa, placental abruption, placenta accreta, placenta increta, and retained placenta. We also included other obstetric and neonatal outcomes like postpartum hemorrhage, ectopic pregnancy, oligohydramnios, gestational hypertension, gestational diabetes mellitus, and intrauterine growth restriction. The results were presented as odds ratios (ORs) with 95% confidence intervals (CIs) in studies with a control group, but otherwise as prevalence (%) with 95% confidence intervals (CIs). RESULTS: The overall pregnancy and live birth rates were 58.97% and 45.56%, respectively. The prevalence of placenta previa differed in pregnant women who underwent hysteroscopic adhesiolysis compared with those who did not (OR, 3.27; 95% CI, 1.28-8.36). In studies without a comparative group, the pooled rate of placenta accreta was 7% (95% CI, 4-11) in 20 studies; placenta increta was 1% (95% CI, 0-4) in 5 studies; a retained placenta was 11% (95% CI, 5-24) in 5 studies; postpartum hemorrhage was 12% (95% CI, 8-18) in 12 studies; ectopic pregnancy was 1% (95% CI, 0-2) in 13 studies; oligohydramnios was 3% (95% CI, 1-6) in 3 studies; intrauterine growth restriction was 3% (95% CI, 1-8) in 3 studies; gestational hypertension was 5% (95% CI, 2-11) in 4 studies; and diabetes mellitus was 4% (95% CI, 2-7) in 3 studies. DISCUSSION: Due to the paucity of good quality comparative data, the question of whether there is an increased prevalence of obstetric and neonatal complications in women after hysteroscopic adhesiolysis compared with the general population remains unanswered. The findings from this review will provide a basis for more well-designed studies in the future. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=364021, identifier [CRD42022364021]. Frontiers Media S.A. 2023-03-24 /pmc/articles/PMC10080075/ /pubmed/37033233 http://dx.doi.org/10.3389/fendo.2023.1126740 Text en Copyright © 2023 Wenzhi, Xin, Ping, Hanglin and Xiaona https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Wenzhi, Xu
Xin, Xu
Ping, Zhou
Hanglin, Wu
Xiaona, Lin
A meta-analysis of obstetric and neonatal outcomes in patients after treatment of hysteroscopic adhesiolysis
title A meta-analysis of obstetric and neonatal outcomes in patients after treatment of hysteroscopic adhesiolysis
title_full A meta-analysis of obstetric and neonatal outcomes in patients after treatment of hysteroscopic adhesiolysis
title_fullStr A meta-analysis of obstetric and neonatal outcomes in patients after treatment of hysteroscopic adhesiolysis
title_full_unstemmed A meta-analysis of obstetric and neonatal outcomes in patients after treatment of hysteroscopic adhesiolysis
title_short A meta-analysis of obstetric and neonatal outcomes in patients after treatment of hysteroscopic adhesiolysis
title_sort meta-analysis of obstetric and neonatal outcomes in patients after treatment of hysteroscopic adhesiolysis
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080075/
https://www.ncbi.nlm.nih.gov/pubmed/37033233
http://dx.doi.org/10.3389/fendo.2023.1126740
work_keys_str_mv AT wenzhixu ametaanalysisofobstetricandneonataloutcomesinpatientsaftertreatmentofhysteroscopicadhesiolysis
AT xinxu ametaanalysisofobstetricandneonataloutcomesinpatientsaftertreatmentofhysteroscopicadhesiolysis
AT pingzhou ametaanalysisofobstetricandneonataloutcomesinpatientsaftertreatmentofhysteroscopicadhesiolysis
AT hanglinwu ametaanalysisofobstetricandneonataloutcomesinpatientsaftertreatmentofhysteroscopicadhesiolysis
AT xiaonalin ametaanalysisofobstetricandneonataloutcomesinpatientsaftertreatmentofhysteroscopicadhesiolysis
AT wenzhixu metaanalysisofobstetricandneonataloutcomesinpatientsaftertreatmentofhysteroscopicadhesiolysis
AT xinxu metaanalysisofobstetricandneonataloutcomesinpatientsaftertreatmentofhysteroscopicadhesiolysis
AT pingzhou metaanalysisofobstetricandneonataloutcomesinpatientsaftertreatmentofhysteroscopicadhesiolysis
AT hanglinwu metaanalysisofobstetricandneonataloutcomesinpatientsaftertreatmentofhysteroscopicadhesiolysis
AT xiaonalin metaanalysisofobstetricandneonataloutcomesinpatientsaftertreatmentofhysteroscopicadhesiolysis